Acute tryptophan or tyrosine depletion test: time for reappraisal?
A. Badawy
DOI: https://doi.org/10.1177/0269881105053312
2005-07-01
Journal of Psychopharmacology
Abstract:The acute tryptophan (ATD; Young et al., 1985) or tyrosine phenylalanine (ATPD; Sheehan et al., 1996) depletion test is a powerful tool widely used to assess serotonin (or dopamine and noradrenaline) function in normal subjects and in a variety of behavioural and other psychological conditions through inducing an acute depletion of the corresponding precursor aminoacid. The test utilizes the following basic principles. (1) Because the rate-limiting enzymes of brain serotonin and dopamine synthesis, Trp and Tyr hydroxylases, are unsaturated with their amino acid substrates (Carlsson and Lindqvist, 1978), brain Trp and Tyr concentrations are the most important single metabolic determinants of synthesis of these monoamines. (2) It therefore follows that peripheral factors influencing circulating Trp and Tyr availability to the brain play important roles in the control of monoamine synthesis. (3) This control is exerted at the primary level by activities of the rate-limiting enzymes of Trp and Tyr degradation, namely liver Trp pyrrolase and Tyr aminotransferase (Badawy, 1977; Badawy et al., 1983), and at the secondary, but more immediate, level by competition between Trp, Tyr and 4 other amino acids (Phe, Val, Leu and Ile), which share the same cerebral uptake mechanism (Fernstrom and Wurtman, 1971; Partridge and Oldendorf, 1975), and, additionally, for Trp, by its binding to albumin (Curzon, 1979). Because of this competition, depletion of a particular monoamine occurs when its amino acid precursor is lowered or totally omitted from a mixture of the above six competitors. It is important to emphasize here that, in the acute depletion test, two events should be recognized: (1) decreased cerebral concentration of the amino acid which has been omitted from the mixture; (2) increased entry of one or more of the five other competing amino acids into the brain as a result of elimination of the competition from the absent amino acid. This latter aspect has so far been overlooked by researchers in this area, not least from the viewpoint of interpretation of behavioural changes, or lack of them. It should also be emphasized here that the reason for this current state of affairs lies primarily with the nature of the test and, in particular, the compositions of the amino acid mixtures, rather than with us as users of the test. Thus, when Trp is being depleted, we are unwittingly increasing dopamine and noradrenaline synthesis and, vice versa, depletion of Tyr plus Phe may increase brain Trp and hence serotonin synthesis. The depletion test literature is full of examples, the latest of which is the paper published in this journal by Lythe et al. (2005), which I should like to quote here purely to illustrate the above points, and not in any way as a criticism of the authors’ work. Lythe et al. (2005) reported and expressed surprise at the lack of mood-lowering and of changes in memory, attention or behavioural inhibition in normal volunteers after ATPD. One possible, if simple, explanation may be that, even if dopamine (and/or noradrenaline) depletion influences, for example, mood, such an effect could have been neutralized by a potentially large increase in serotonin under the authors’ experimental conditions. Thus, I have calculated from the data in Table 1 of the Lythe et al. (2005) paper that, while the [Tyr Phe]/[LNAA] ratio was decreased from a baseline value of 0.225 to 0.005 at 4h after administration of the ATPD test, that of [Trp]/[LNAA], including Tyr and Phe, underwent a dramatic three-fold elevation, from a baseline value of 0.133 to 0.398. Under these conditions, one expects cerebral serotonin synthesis to have reached maximal capacity, possibly a two-fold increase at most, because of negative feedback control mechanisms. Even the supposedly balanced amino acid mixture (containing all six competitors) causes changes in the above ratios. In the paper by Lythe et al. (2005), following the balanced mixture, the [Tyr Phe]/[LNAA] ratio was decreased from a baseline vale of 0.209 to 0.109, whereas that of [Trp]/[LNAA] was elevated from a baseline value of 0.110 to 0.403. It is clear from this account that major changes are required in the formulation of the amino acid mixtures used in the above depletion tests. The following points are worthy of consideration. (1) Comparing changes in ratios after acute depletion with those observed in the ‘balanced’ condition would, in my view, be unjustified, if the latter ratios have changed from baseline values. (2) Similarly, it is not appropriate to compare behavioural data between the ‘depletion’ and the ‘balanced’ conditions, if the latter alters baseline behaviour. (3) Baseline behaviour should therefore be assessed, if the experimental set-up or the nature of the study allows, in a separate ‘placebo’ condition. (4) We need to modify the ‘balanced’ formulation in such a way that we do not end up with ‘unbalanced’ ratios. (5) Finally, we should also aim to modify the composition of the depleted mixtures, such that a decrease in the [Trp]/[LNAA] ratio will not be associated with an increased [Tyr Phe]/[LNAA] ratio or vice versa. Only when we achieve this level of specificity and control will we be able to make the most of the acute depletion test and interpret behavioural